Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 828 of 1,261
  1. US 8664227

    Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

    Theravance, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  2. US 8664219

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  3. US 8663705

    Method and apparatus for producing a stabilized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic

    Reoxcyn Discoveries Group, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  4. US 8664251

    Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

    The Regents of the University of California · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted
  5. US 8658154

    Humanized FcγR mice

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  6. US 8658158

    Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

    ONCOLYTICS BIOTECH INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  7. US 8658168

    Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  8. US 8658626

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  9. US 8658778

    hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  10. US 8658211

    Polyconjugates for in vivo delivery of polynucleotides

    Arrowhead Madison, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  11. US 8658236

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Deuteria Beverages, LLC · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  12. US 8658616

    Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus

    University College Cardiff Consultants Limited · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  13. US 8658356

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  14. US 8658622

    Methods and compositions for preventing and treating a disease related to glycan dysregulation

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  15. US 8658664

    Cyclopamine tartrate salt and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  16. US 8658627

    Pregnancy hormone combination for treatment of autoimmune diseases

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  17. US 8658669

    Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  18. US 8658671

    Crystalline form of a quinolinone-carboxamide compound

    Theravance, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  19. US 8658694

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    United Therapeutics Corporation · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  20. US 8658691

    Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound

    Theravance, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  21. US 8658682

    (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone dihydrate and methods of its use

    LEXICON PHARMACEUTICALS, INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  22. US 8658603

    Compositions and methods for inducing an immune response

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  23. US 8658648

    Modified chloroquines with single ring moiety or fused ring moiety

    DesignMedix, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  24. US 8658674

    Thiophene analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.